Identifying Bronchiectasis: Key Clinical Presentations to Consider

Respiratory diseases made up the hospitalizations in older adults after they were exposed to wildfire smoke.

On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.

Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.

These data from the Environmental Protection Agency were presented at the Society for Risk Analysis annual meeting.

New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory syncytial virus (RSV).